observation is consistent with earlier studies that have suggested that the consumption of a low-143 MAC Western diet enriches for muciniphilic bacteria [40, 42, 48] . 144
Overall, host diet appears to have a major impact on the structure on the microbiome during 145 ciprofloxacin treatment. While ciprofloxacin did not induce a significant reduction in alpha 146 diversity in the timeframe tested, at the phylum level we observed a significant expansion in the 147 relative abundance of Firmicutes following ciprofloxacin treatment on the Western diet (adjusted 148 p-value = 0.0388) but not on the control diet (adjusted p-value = 0.8718) ( Figure 1C ). To determine 149 which species displayed a differential response to ciprofloxacin on the Western and control diets, 150
we utilized DESeq2 to analyze the interaction between diet and antibiotic treatment [58] . An 151 interaction term describes the direction and magnitude of the differential impact that host diet has 152 on antibiotic perturbation within the microbiome. For example, ciprofloxacin reduces the 153 abundance of Clostridium innocuum on the control diet, while it expands following treatment on 154 the Western diet ( Figure 1E , Additional File 1); thus, the interaction term in this case is positive, 155
as it indicates an expansion on the Western diet relative to control following ciprofloxacin 156 exposure. 157
While most species responded similarly to ciprofloxacin therapy on both diets, there were 158 several notable exceptions. For example, the expansion of several Clostridium species (such as C. 159 innocuum, Clostridium beijerinckii, and Clostridium scindens) following ciprofloxacin tended to 160 be higher on the Western diet than the control (denoted by a positive interaction value in Figure  161 1E, Additional File 1). Conversely, the reduction of several Bacteroides species following 162 antibiotic treatment tended to be exacerbated on the Western diet (negative interaction values, 163 Figure 1E , Additional File 1). In particular, the reduction of B. thetaiotaomicron in response to 164 ciprofloxacin was enhanced on the Western diet; in contrast, dietary composition had no 165 significant impact on the response of A. muciniphila to ciprofloxacin ( Figure 1F+G , Additional 166 File 1). Lastly, Western diet consumption appeared to have the most detrimental impact on Blautia 167 sp. YL58 during ciprofloxacin therapy, as evidenced by its large, negative interaction term ( Figure  168 1H, Additional File 1). While ciprofloxacin did not significantly reduce the abundance of Blautia 169 sp. YL58 in mice consuming the control diet, this bacterium was completely undetectable 170 following treatment on the Western diet. This is particularly notable because this species was 171 present in comparable levels in vehicle-treated animals on both the Western and control diets 172 ( Figure 1H , Additional File 1). 173 174
Ciprofloxacin Elicits Unique Shifts in Gene Expression on Western and Control Diets 175
Though many studies have examined the impacts of either diet or antibiotic treatment on 176 the gut microbiome, few have examined their combined effect on the composition or gene 177 expression of these communities. To address this, we first analyzed our metatranscriptomic dataset 178 using the HUMAnN2 pipeline, which normalizes the abundance of RNA transcripts against their 179 corresponding gene abundance in the metagenomic data [59] . Thus, this tool normalizes for 180 differences in community composition between experimental groups and facilitates the 181 comparison of metabolic pathway expression at the whole-community level. A comparison of the 182 transcriptional profile of all experimental groups demonstrates that the microbiota of mice 183 consuming the Western diet display elevated expression of tricarboxylic acid (TCA) cycle and 184 fatty acid degradation pathways in both vehicle and ciprofloxacin treatments, likely reflective of 185 the increased fat and sugar content of this diet (Figure 2A , Additional File 2). Additionally, we 186
Western diet. This family of glycoside hydrolases is known to include endo-beta-galactosidase, an 258 enzyme that cleaves AB blood group surface antigens and has been shown to play a role in the 259 virulence of organisms such as Clostridium perfringens and Streptococcus pneumoniae [67] . On 260 the Western diet, we observed that ciprofloxacin treatment reduced the abundance of transcripts 261 encoding a cluster of sulfate reductases, which may indicate a broader role for these enzymes 262 during antibiotic treatment. Among the transcripts that were increased in abundance on this diet 263 were several that encoded flagellin and related proteins, which can play a role in pathogenicity 264 [68, 69] (Figure 3F , Additional File 4). Additionally, we found increases in transcript levels of 265 several phage-related genes, which has been observed previously in response to ciprofloxacin 266 treatment [20] ( Figure 3F , Additional File 4). 267
Lastly, we examined the interaction of diet and antibiotic treatment on transcript abundance 268 within the microbiome. Notably, we found that the transcript abundance of several sporulation 269 genes following ciprofloxacin treatment was significantly higher on the Western diet than the 270 control ( Figure 3G , Additional File 4). Additionally, transcripts encoding phosphotransferase 271 system (PTS) transporters of various substrates (such as cellobiose, fructose, and N-272 acetylgalactosamine) were also found to be higher on the Western diet following ciprofloxacin 273 treatment ( Figure 3G , Additional File 4). Conversely, consumption of the Western diet 274 significantly reduced the change in transcript abundance of both pectate lyase and a hemin receptor 275 following ciprofloxacin therapy. Together, these findings demonstrate that dietary composition 276 significantly impacts the transcriptional response of the microbiome to ciprofloxacin. 277
278 Host diet has a major impact on the transcript abundance of antibiotic resistance and 279 virulence factor genes 280 Previous work has suggested that dietary composition may promote the virulence of several 281 known bacterial pathogens [20, [70] [71] [72] [73] . Furthermore, the emergence of antibiotic resistance genes 282 (ARGs) during clinical therapy threatens the efficacy of many drugs [74] . Therefore, we sought to 283 profile the impact of diet and ciprofloxacin treatment on the abundance of known ARG and 284 virulence factor transcripts within the microbiome. Overall, diet appeared to have the most 285 dramatic impact on the abundance of ARG transcripts at the class level ( Figure 4A , Additional 286
File 5). The microbiota of mice consuming the Western diet had an elevated abundance of ARG 287 transcripts against fosmidomycin, beta-lactam, glycopeptide and peptide antibiotics ( Figure 4A , 288 Additional File 5). The observed increase in glycopeptide ARGs appears be driven primarily by 289 increased transcript levels of four genes that confer resistance to vancomycin (vanG, vanN, vanE, 290 and vanL, Additional File 6). Conversely, Western diet-fed mice also exhibited decreased 291 abundances of transcripts encoding ARGs against tetracycline, mupirocin, bacitracin, and phenicol 292 antibiotics ( Figure 4A , Additional File 5). 293
Interestingly, ciprofloxacin treatment did not elicit major shifts in class-level ARG 294 transcript abundance on either diet. On the Western diet, we observed statistically significant 295 changes in two ARG classes (an increase in oxazolidinone and a decrease in unclassified ARGs) 296 while ciprofloxacin only changed the abundance of a single class on the control diet (an increase 297 in beta-lactam ARGs). However, ciprofloxacin did elicit numerous changes in the transcript 298 abundance of several individual ARGs on both diets (Additional File 6). On the Western diet, 299 ciprofloxacin increased the abundance of transcripts encoding three tetracycline resistance genes 300 (tetB(60), tetB(46), and otrA) while decreasing expression of several efflux pumps (mefA, mexW, 301 mexB, and oprA). Interestingly, several of the transcripts encoding efflux pumps that were reduced 302 with ciprofloxacin treatment on the Western diet were increased on the control diet (mexW, mefA) 303 along with several other ARGs from this class (mexQ, mexF). Together, these findings suggest 304 that host diet influences the abundance of resistance genes during antibiotic therapy. Additionally, 305 it appears that ciprofloxacin treatment has a comparatively minor impact on the abundance of ARG 306 transcripts within the microbiota relative to host diet. It is important to note that this analytical 307 pipeline does not account for changes in population structure induced by each of the perturbations. 308
As a result, some of the discussed changes in transcript abundance may result from differential 309 bacterial abundances. For example, the Western diet induced an expansion in B. thetaiotaomicron, 310 a bacterium that typically encodes beta-lactamases [20,75-79]. Thus, this may partially explain the 311 higher observed levels of beta-lactam resistance in this condition. 312
Diet and ciprofloxacin treatment also had a major impact on the abundance of transcripts 313 encoding known virulence factors. In total, we detected 351 virulence factor transcripts with 314 altered abundances on the Western diet (Additional File 7). Supporting our earlier observation 315 ( Figure 3D , Additional File 7), we found that the microbiota of the mice consuming the Western 316 diet displayed an increased transcript abundance of numerous enzymes known to hydrolyze host-317 derived proteinsspecifically, hyaluronidase, neuraminidase, sialidase, and exo-alpha-sialidase 318 ( Figure 4B , Additional File 7). Additionally, mice consuming a Western diet displayed higher 319 transcript abundances of catalase and superoxide dismutase, which may be indicative of oxidative 320 stress ( Figure 4B , Additional File 7). In total, ciprofloxacin treatment altered the abundance of 139 321 and 90 virulence factor transcripts on the control and Western diets, respectively (Figures 4C+D, 322 Additional File 7). Of note on the control diet, ciprofloxacin increased the abundance of transcripts 323 of sialidase, catalase, a glucose/galactose transporter, and the outer membrane protein OmpA while 324 simultaneously reducing the abundance of transcripts related to urease, iron permease, ferric 325 siderophores, bile salt hydrolase, and twitching motility ( Figure 4C , Additional File 7). On the Western diet, ciprofloxacin increased the transcript abundance of several iron-related virulence 327 factors such as an iron-regulated transporter, hemolysin B, and a hemolysin transport protein 328 ( Figure 4D , Additional File 7). Lastly, we examined the interaction of both diet and ciprofloxacin 329 treatment on the abundance of transcripts encoding virulence factors ( Figure 4E , Additional File 330 7). Interestingly, we observed that the change in transcript abundance of catalase, superoxide 331 dismutase, hyaluronidase, sialidase, and exo-alpha-sialidase following ciprofloxacin 332 administration were all significantly lower on the Western diet relative to the control ( Figure 4E , 333 Additional File 7). However, we previously observed that the baseline levels of these transcripts 334 were significantly elevated in the Western diet before treatment ( Figure 4B , Additional File 7). 335 Therefore, it is likely that the reduced expansion of these transcripts following ciprofloxacin 336 treatment on the Western diet is attributable to their high, pre-treatment baseline levels. 337 338
Diet and ciprofloxacin alter gene expression within B. thetaiotaomicron and A. muciniphila 339
All metatranscriptomic analysis conducted thus far has examined the impact of diet and 340 ciprofloxacin treatment on the transcriptional activity of the microbiome at the whole community 341 level. However, we sought to profile how these factors impacted individual species within the 342 microbiota. Thus, we used a previously published pipeline to interrogate the impact of diet and 343 antibiotic treatment on two individual species: B. thetaiotaomicron and A. muciniphila [20, 80] . 344
We focused on these bacteria because they are known human gut commensals, were found in 345 relatively high levels in all samples analyzed, and because they were differentially abundant in a 346 diet-dependent manner. 347
Interestingly, we found that A. muciniphila displayed increased expression of several 348 known stress response genes on the Western diet ( Figure 5A these changes in gene expression may be reflective of the primary mechanism of action of this 412 antibiotic and are consistent with previously published data [20] . Furthermore, our ability to detect 413 such changes is an important indication that our analysis is detecting ciprofloxacin-induced 414 transcriptional shifts. Lastly, diet appears to have a significant impact on ciprofloxacin-induced 415 transcriptional changes within B. thetaiotaomicron, modulating the response of 148 genes 416 (Additional File 9). Of note, Western diet consumption in the context of ciprofloxacin treatment 417 had a negative impact on several genes involved in the acquisition of nutrients, such as vitamin 418 B12 and hemin receptors, and transporters of glucose/galactose, hexuronate, arabinose, and Na+ 419 (Additional File 9). Thus, it is likely that the availability of nutrients within the gut plays a role in 420 the response of these bacteria to antibiotics. 421
Discussion: 422
Previous work has demonstrated that host diet, particularly with respect to sugar and fiber 423 content, plays a major role in the extent of antibiotic-induced microbiome disruption [20] . In 424
Western societies, many people consume a diet high in added sugars and fat, but low in host-425 indigestible fiber. It is thought that such a composition promotes the development of metabolic 426 syndrome, heart disease, diabetes, and a number of other chronic conditions [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] . Furthermore, 427 broad-spectrum antibiotic use and resulting microbiome dysbiosis have been associated with a 428 number of similar co-morbidities along with increased susceptibility to opportunistic infections 429 [1, [5] [6] [7] [21] [22] [23] 25, 26] . Despite this connection, little work has been done examining how host dietary 430 composition impacts the response of the microbiota to antibiotic perturbation. It is known that 431 nutrient availability and metabolic state are a major determinant of antibiotic susceptibility of 432 bacteria in vitro [20,60-63,91-97]. Thus, it is likely that modulating host diet, thus changing the 433 availability of nutrients to the microbiota, would alter the sensitivity of bacteria in these 434 communities to antibiotic therapy. 435
To address this knowledge gap, we utilized a combined metagenomic and 436 metatranscriptomic approach to profile taxonomic and functional changes in response to both diet 437 and antibiotic treatment. By utilizing these tools in parallel, we are able to link transcriptional 438 changes to observed shifts in community structure on each diet. Using metagenomics, we observed 439 that ciprofloxacin had a differential impact on community composition that was diet-dependent. 440
Specifically, we observed a statistically significant expansion of the Firmicutes phylum following 441 ciprofloxacin treatment on the Western, but not control, diet. Using metatranscriptomics, we 442 observed that ciprofloxacin treatment resulted in a decreased abundance of transcripts from the 443 TCA cycle in both diets, suggesting that this response is diet-independent. Furthermore, this 444 were reflective of stress responses, we also observed that transcripts involved in diverse cellular 454 processes such as nutrient acquisition, carbon metabolism, and capsular polysaccharide (CPS) 455 biosynthesis were differentially expressed as well. 456
Despite the advantages of a multi-omic approach, there are a number of drawbacks to these 457 our transcriptional analysis of B. thetaiotaomicron showed that this bacterium differentially 468 expressed receptors for both hemin and vitamin B12, which may suggest that these nutrients play 469 a role in ciprofloxacin toxicity. Alternatively, it is possible that these transcriptional changes are 470 reflective of increased availability of these nutrients due to decreased competition from other 471 members of the microbiota (though these hypotheses are not mutually exclusive). Additionally, it 472 is possible that dietary composition could play a significant role in antibiotic absorption or 473 sequestration in the gut, which in turn would impact the extent of the damage caused to the 474 microbiota. 475
This study builds on recent work that demonstrates that the availability of metabolites to Despite these promising applications, considerable work is required before these findings have 484 direct clinical relevance. In particular, the considerable differences in physiology, microbiome 485 composition, and diet between humans and rodents complicate the direct clinical relevance of these 486 findings. Furthermore, it is unclear which components of diet are responsible for the observed 487 effects and whether short-term dietary modulation has any long-term consequences on either the 488 host or the microbiome. Thus, additional research is warranted to fully elucidate how host diet 489 impacts antibiotic-induced microbiome disruption in humans. 490 491
Conclusions: 492
Using a combined metagenomic and metatranscriptomic approach, we demonstrate that 493 murine diet composition has a major impact on the response of the murine gut microbiome to 494 ciprofloxacin therapy. First, we found that the gut microbiome undergoes differential shifts in 495 community structure in response to antibiotic treatment in a diet-dependent manner. At the 496 transcriptional level, we found that ciprofloxacin reduced the abundance of TCA cycle transcripts 497 regardless of diet, suggesting that central carbon metabolism plays a role in the activity of this 498 antibiotic in vivo. Despite this commonality, we observed extensive differences in the 499 transcriptional response of the microbiome to dietary intervention and/or ciprofloxacin treatment. 500
Most notably, we found that diet had a major impact on the abundance of transcripts encoding 501 known virulence and antibiotic resistance genes within the gut microbiome. Mice consuming a 502
Western diet had a high abundance of transcripts encoding proteins known to degrade host-derived 503 polysaccharides such as sialic residues of mucin, suggesting that the consumption of this diet may 504 have detrimental impacts on host physiology. Lastly, we identified species-specific changes in 505 transcript abundance in two key members of the gut microbiome, A. muciniphila and B. 506 thetaiotaomicron. In A. muciniphila, consumption of a Western diet increased the expression of 507 several genes known to play a role in stress responses. In B. thetaiotaomicron, we found that a 508 number of genes involved in CPS biosynthesis were differentially expressed during ciprofloxacin 509 treatment on the control but not Western diet, which may suggest a divergent response of this 510 bacterium to ciprofloxacin that is dependent on nutrient composition. Taken together, these 511 
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